Hopes Rises as Nigerian Priests Develop COVID-19 Drug

Spread the love

A supposed cure for the deadly coronavirus has been developed by a group of Nigerian Catholic priests – The drug is called Pax CVD Plus, and it is said to be solely for the treatment of coronavirus – The constituents of the drug are antiviral and immunomodulatory agents which help to stimulate antibodies A group of Nigerian Catholic priests have developed a supposed cure for the deadly COVID-19 pandemic, a drug called Pax CVD Plus. The disclosure was made in a statement released and signed by Father Anselm Adodo OSB on Wednesday, April 29, on the official page of the Pax Herbal Clinic and Research Laboratories, Outcome News reports.

Legit.ng notes that the cleric said the drug is solely for the treatment of coronavirus. Father Anselm said that plant-based drugs are seemingly the best approach for coronavirus because these drugs are easily produced, stored and distributed and can be handled by medical and non-medical personnel as they pose a low contamination risk. Hope rises as German company begins human trials of coronavirus vaccine The constituents of the drug are antiviral and immunomodulatory agents which help to stimulate antibodies. News Source: UGC He said the constituents of the drug are antiviral and immunomodulatory agents which help to stimulate antibodies. The cleric said: “The Pax CVD PLUS contains herbs and active phytoconstituents with documented scientific evidence based on clinical reports of their efficacy and safety.” According to Father Anselm, the research is a joint effort of experts from University of Lagos and University of Benin, a tertiary health institution—Irrua Specialist Teaching Hospital, Edo state and experts sent by Prof Tunde Salako and Prof Catherine Adeyeye. Professor Salako is the head of the National Institute of Pharmaceutical Research and Development, while Professor Adeyeye is the director-general of the National Agency for Food and Drug Administration and Control.

About The Author


Spread the love

Leave a Reply

Your email address will not be published.